Literature DB >> 14747927

[Optimizing the use of radiotherapy with IMRT and image guided location of advanced prostate cancer].

F Lohr1, M Fuss, U Tiefenbacher, M Siegsmund, S Mai, J M Kunnappallil, B Dobler, P Alken, F Wenz.   

Abstract

Intensity modulated radiotherapy (IMRT) combined with recently developed noninvasive image-guided targeting techniques for tumor localization/repositioning provide a means to further improve on conformal radiotherapy of prostate cancer by optimally sparing the rectum. This refined approach may potentially improve treatment results for locally advanced prostate cancer while reducing side effects. This review summarizes the clinical requirements for effective prostate radiotherapy and describes the new technology that helps to better fulfil these requirements. These noninvasive developments, their potential benefit as well as their limitations, together with new data on fractionation sensitivity of prostate cancer that may lead to shortened overall treatment times may be of interest for all physicians treating patients with prostate cancer.

Entities:  

Mesh:

Year:  2004        PMID: 14747927     DOI: 10.1007/s00120-003-0481-6

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  46 in total

1.  Hypofractionation for prostate cancer.

Authors:  J P Logue; R A Cowan; J H Hendry
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-04-01       Impact factor: 7.038

2.  Intensity-modulated radiotherapy - technology and clinical applications.

Authors:  B H Didinger; W Schlegel; J Debus
Journal:  Onkologie       Date:  2002-06

Review 3.  Intensity-modulated radiation therapy.

Authors:  Thomas E Goffman; Eli Glatstein
Journal:  Radiat Res       Date:  2002-07       Impact factor: 2.841

4.  Experience of ultrasound-based daily prostate localization.

Authors:  Anurag Chandra; Lei Dong; Eugene Huang; Deborah A Kuban; Laura O'Neill; Isaac Rosen; Alan Pollack
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-06-01       Impact factor: 7.038

Review 5.  Daily stereotactic ultrasound prostate targeting: inter-user variability.

Authors:  Martin Fuss; Sean X Cavanaugh; Cristina Fuss; Dennis A Cheek; Bill J Salter
Journal:  Technol Cancer Res Treat       Date:  2003-04

6.  Prostate preservation by combined external beam and HDR brachytherapy in nodal negative prostate cancer.

Authors:  G Kovács; R Galalae; T Loch; H Bertermann; P Kohr; R Schneider; B Kimming
Journal:  Strahlenther Onkol       Date:  1999-06       Impact factor: 3.621

7.  A comparison of daily CT localization to a daily ultrasound-based system in prostate cancer.

Authors:  J Lattanzi; S McNeeley; W Pinover; E Horwitz; I Das; T E Schultheiss; G E Hanks
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-03-01       Impact factor: 7.038

8.  Fractionation and protraction for radiotherapy of prostate carcinoma.

Authors:  D J Brenner; E J Hall
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-03-15       Impact factor: 7.038

9.  Intrafraction prostate motion during IMRT for prostate cancer.

Authors:  Eugene Huang; Lei Dong; Anurag Chandra; Deborah A Kuban; Isaac I Rosen; Anissa Evans; Alan Pollack
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-06-01       Impact factor: 7.038

Review 10.  Localized carcinoma of the prostate (stages T1B, T1C, T2, and T3). Review of management with external beam radiation therapy.

Authors:  C A Perez; G E Hanks; S A Leibel; A L Zietman; Z Fuks; W R Lee
Journal:  Cancer       Date:  1993-12-01       Impact factor: 6.860

View more
  4 in total

1.  [Image-guided radiation therapy].

Authors:  J Boda-Heggemann; M Guckenberger; U Ganswindt; C Belka; H Wertz; M Blessing; F Wenz; M Fuss; F Lohr
Journal:  Radiologe       Date:  2012-03       Impact factor: 0.635

2.  [Radiation therapy for prostate cancer in the new S3 guideline. Part 1: localized and locally advanced prostate cancer].

Authors:  D Böhmer; F Wenz; T Martin; F Sedlmayr; W Hinkelbein; T Wiegel
Journal:  Urologe A       Date:  2010-02       Impact factor: 0.639

3.  The German S3 guideline prostate cancer: aspects for the radiation oncologist.

Authors:  Frederik Wenz; Thomas Martin; Dirk Böhmer; Stefan Martens; Felix Sedlmayer; Manfred Wirth; Kurt Miller; Axel Heidenreich; Mark Schrader; Wolfgang Hinkelbein; Thomas Wiegel
Journal:  Strahlenther Onkol       Date:  2010-09-30       Impact factor: 3.621

4.  Reduced rectal toxicity with ultrasound-based image guided radiotherapy using BAT (B-mode acquisition and targeting system) for prostate cancer.

Authors:  Markus Bohrer; Peter Schröder; Grit Welzel; Hansjörg Wertz; Frank Lohr; Frederik Wenz; Sabine Kathrin Mai
Journal:  Strahlenther Onkol       Date:  2008-12-24       Impact factor: 3.621

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.